Table 1.
Subject demographics and baseline disease characteristics (full analysis set).
| Characteristic | IncobotulinumtoxinA (n = 171) | Placebo (n = 88) |
|---|---|---|
| Men, n (%) | 97 (56.7) | 50 (56.8) |
| Mean (SD) age, years | 55.4 (11.7) | 57.1 (10.8) |
| Race, n (%) | ||
| White | 136 (79.5) | 73 (83.0) |
| Black or African American | 6 (3.5) | 2 (2.3) |
| Asian | 27 (15.8) | 13 (14.8) |
| Other | 2 (1.2) | 0 |
| Mean (SD) BMI, kg/m2 | 27.0 (4.5) | 27.0 (3.9) |
| Median (range) time since last stroke leading to spasticity, months | 28.0 (4–277) | 27.8 (3–412) |
| Median (range) time since first diagnosis of upper‐limb spasticity, months | 11.8 (0–270) | 12.0 (0–257) |
| Clinical pattern(s) of upper limb spasticity, n (%) | ||
| Adducted or internally rotated shoulder | 87 (50.9) | 49 (55.7) |
| Flexed elbow | 171 (100.0) | 88 (100.0) |
| Pronated forearm | 151 (88.3) | 75 (85.2) |
| Flexed wrist | 171 (100.0) | 88 (100.0) |
| Thumb‐in‐palm | 104 (60.8) | 52 (59.1) |
| Clenched fist | 171 (100.0) | 88 (100.0) |
| Intrinsic plus hand | 22 (12.9) | 5 (5.7) |
BMI, body mass index; SD, standard deviation.